Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Dianthus Therapeutics, Inc.(DNTH) | 2,104,184 | 2,104,184 | 0 | $176.58M | $205.12M | 32.85% | +$28.53M |
| CG Oncology, Inc.(CGON) | 1,288,948 | 1,398,948 | +110,000 | $87.24M | $99.40M | 15.92% | +$12.16M |
| Oruka Therapeutics, Inc.(ORKA) | 760,424 | 760,424 | 0 | $37.30M | $72.37M | 11.59% | +$35.07M |
| Jade Biosciences Inc | 1,400,708 | 1,700,708 | +300,000 | $19.68M | $37.79M | 6.05% | +$18.11M |
| Enliven Therapeutics Inc | 400,000 | 550,000 | +150,000 | $15.68M | $27.91M | 4.47% | +$12.23M |
| Perspective Therapeutics, Inc.(CATX) | 6,049,999 | 6,299,999 | +250,000 | $25.23M | $21.48M | 3.44% | -$3.75M |
| Aktis Oncology, Inc.(AKTS) | 468,566 | 484,200 | +15,634 | $8.38M | $15.61M | 2.50% | +$7.22M |
| Palvella Therapeutics, Inc.(PVLA) | 70,000 | 70,000 | 0 | $8.73M | $10.70M | 1.71% | +$1.97M |
| Mobia Med Inc | 0 | 798,282 | +798,282 | $0 | $10.70M | 1.71% | +$10.70M |
| Repligen Corporation(RGEN) | 77,800 | 77,800 | 0 | $9.17M | $10.62M | 1.70% | +$1.45M |
| Immunic, Inc.(IMUX) | 0 | 669,941 | +669,941 | $0 | $10.30M | 1.65% | +$10.30M |
| Senseonics Holdings, Inc.(SENS) | 0 | 1,600,000 | +1,600,000 | $0 | $9.09M | 1.46% | +$9.09M |
| Karyopharm Therapeutics Inc.(KPTI) | 463,741 | 924,487 | +460,746 | $2.58M | $9.03M | 1.45% | +$6.45M |
| Teva Pharmaceutical Industries LimitedADS(TEVA) | 450,100 | 200,000 | -250,100 | $13.56M | $6.78M | 1.09% | -$6.78M |
| DexCom, Inc.(DXCM) | 90,000 | 100,000 | +10,000 | $5.65M | $6.74M | 1.08% | +$1.08M |
| Tempus AI, Inc.CL A(TEM) | 25,000 | 105,000 | +80,000 | $1.13M | $6.08M | 0.97% | +$4.95M |
| Medtronic plcSHS(MDT) | 100,000 | 70,000 | -30,000 | $8.66M | $5.48M | 0.88% | -$3.19M |
| Vir Biotechnology, Inc.(VIR) | 950,000 | 519,300 | -430,700 | $8.51M | $5.29M | 0.85% | -$3.22M |
| Structure Therapeutics IncADS | 30,000 | 98,000 | +68,000 | $1.45M | $5.26M | 0.84% | +$3.81M |
| Encompass Health Corporation(EHC) | 42,000 | 42,000 | 0 | $4.06M | $4.25M | 0.68% | +$182.7K |
| Tenax Therapeutics, Inc.(TENX) | 215,934 | 265,934 | +50,000 | $3.45M | $3.87M | 0.62% | +$416.6K |
| Nuvectis Pharma, Inc.(NVCT) | 0 | 200,000 | +200,000 | $0 | $3.68M | 0.59% | +$3.68M |
| Insulet Corporation(PODD) | 0 | 24,000 | +24,000 | $0 | $3.65M | 0.59% | +$3.65M |
| Boston Scientific Corporation(BSX) | 60,000 | 80,000 | +20,000 | $3.77M | $3.41M | 0.55% | -$350.6K |
| Satellos Bioscience Inc.(MSLE) | 387,769 | 387,769 | 0 | $2.18M | $3.01M | 0.48% | +$831.8K |
| Alamar Biosciences Inc | 0 | 110,000 | +110,000 | $0 | $2.98M | 0.48% | +$2.98M |
| Context Therapeutics Inc.(CNTX) | 4,998,267 | 4,998,267 | 0 | $13.10M | $2.77M | 0.44% | -$10.33M |
| Gilead Sciences, Inc.(GILD) | 20,000 | 20,000 | 0 | $2.79M | $2.53M | 0.40% | -$260.6K |
| Charles River Laboratories International, Inc.(CRL) | 0 | 10,000 | +10,000 | $0 | $2.27M | 0.36% | +$2.27M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 249,390 | 200,000 | -49,390 | $2.77M | $2.17M | 0.35% | -$600.7K |
| Avalyn Pharmaceuticals Inc | 0 | 60,000 | +60,000 | $0 | $1.98M | 0.32% | +$1.98M |
| Kailera Therapeutics Inc | 0 | 80,000 | +80,000 | $0 | $1.76M | 0.28% | +$1.76M |
| Genmab A/SADS(GMAB) | 50,000 | 50,000 | 0 | $1.34M | $1.37M | 0.22% | +$32.0K |
| Intellia Therapeutics, Inc.(NTLA) | 75,000 | 75,000 | 0 | $961.5K | $1.27M | 0.20% | +$307.5K |
| Corvus Pharmaceuticals, Inc.(CRVS) | 115,000 | 80,000 | -35,000 | $1.68M | $1.20M | 0.19% | -$487.3K |
| Oddity Tech LtdCL A SHS CL A | 70,000 | 70,000 | 0 | $936.6K | $1.06M | 0.17% | +$122.5K |
| Scynexis Inc | 0 | 260,206 | +260,206 | $0 | $1.06M | 0.17% | +$1.06M |
| Evommune, Inc.(EVMN) | 0 | 75,000 | +75,000 | $0 | $996.8K | 0.16% | +$996.8K |
| Abbott Laboratories | 0 | 10,000 | +10,000 | $0 | $907.4K | 0.15% | +$907.4K |
| BridgeBio Pharma, Inc.(BBIO) | 0 | 10,000 | +10,000 | $0 | $744.8K | 0.12% | +$744.8K |
| Peloton Interactive, Inc.CL A(PTON) | 200,000 | 100,000 | -100,000 | $858.0K | $591.0K | 0.09% | -$267.0K |
| Legend Biotech CorporationADS(LEGN) | 0 | 15,000 | +15,000 | $0 | $433.2K | 0.07% | +$433.2K |
| BridgeBio Oncology Therapeutics, Inc.(BBOT) | 43,853 | 43,853 | 0 | $392.5K | $334.2K | 0.05% | -$58.3K |
| Savara Inc.(SVRA) | 0 | 50,000 | +50,000 | $0 | $308.0K | 0.05% | +$308.0K |
| Trevi Therapeutics, Inc.(TRVI) | 6,660 | 6,660 | 0 | $79.5K | $124.2K | 0.02% | +$44.8K |
| ABIVAX Société AnonymeADS(ABVX) | 10,000 | 0 | -10,000 | $1.11M | $0 | — | -$1.11M |
| Acadia Pharm | 12,967 | 0 | -12,967 | $288.6K | $0 | — | -$288.6K |
| Anteris Technologies Global Corp.(AVR) | 150,000 | 0 | -150,000 | $832.5K | $0 | — | -$832.5K |
| Arbutus Biopharma Corporation(ABUS) | 125,000 | 0 | -125,000 | $562.5K | $0 | — | -$562.5K |
| Centene Corporation(CNC) | 70,000 | 0 | -70,000 | $2.29M | $0 | — | -$2.29M |
| Corcept Therapeutics Incorporated(CORT) | 30,000 | 0 | -30,000 | $1.21M | $0 | — | -$1.21M |
| Hims & Hers Health, Inc.CL A(HIMS) | 75,000 | 0 | -75,000 | $1.56M | $0 | — | -$1.56M |
| ICON Public Limited CompanySHS(ICLR) | 16,000 | 0 | -16,000 | $1.77M | $0 | — | -$1.77M |
| Immunic, Inc.(IMUX) | 6,699,411 | 0 | -6,699,411 | $7.44M | $0 | — | -$7.44M |
| Kenvue Inc.(KVUE) | 100,000 | 0 | -100,000 | $1.72M | $0 | — | -$1.72M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 50,000 | 0 | -50,000 | $932.0K | $0 | — | -$932.0K |
| Natera, Inc.(NTRA) | 9,000 | 0 | -9,000 | $1.80M | $0 | — | -$1.80M |
| Revolution Medicines, Inc.(RVMD) | 15,000 | 0 | -15,000 | $1.46M | $0 | — | -$1.46M |
| SCYNEXIS, Inc.(SCYX) | 2,081,660 | 0 | -2,081,660 | $1.91M | $0 | — | -$1.91M |
| UnitedHealth Group Incorporated(UNH) | 3,800 | 0 | -3,800 | $1.03M | $0 | — | -$1.03M |